Clinical trial
The Effect of Intravenous Tranexamic Acid on Blood Loss and Transfusion After Periacetabular Osteotomy: a Prospective, Double-blinded, Randomized Controlled Trial
NCT02253810 is registered in ClinicalTrials.gov with Hospital for Special Surgery, New York as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Intravenous Tranexamic Acid on Blood Loss and Transfusion After Periacetabular Osteotomy: a Prospective, Double-blinded, Randomized Controlled Trial
- Lead sponsor
- Hospital for Special Surgery, New York
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 31, 2014
- Completion date
- October 31, 2018
- Enrollment
- 89 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dysplasia, congenital hip